Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,298 | -111,566 | -166,014 | -174,523 | -60,011 |
| Depreciation Amortization | 1,245 | 1,371 | 1,172 | 492 | 9 |
| Accounts payable and accrued liabilities | -2,920 | -2,295 | -7,804 | 14,494 | 1,961 |
| Other Working Capital | -12,467 | -18,012 | 18,518 | 28,667 | -111 |
| Other Operating Activity | 22,215 | 57,484 | 65,738 | 13,828 | 27,423 |
| Operating Cash Flow | $-81,225 | $-73,018 | $-88,390 | $-117,042 | $-30,729 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -374 | -3,869 | -20,619 | -15,304 | -82 |
| Purchase Sale Intangibles | N/A | -3,500 | -4,250 | -6,250 | -9,000 |
| Other Investing Activity | 11 | -3,483 | -4,311 | -6,250 | -9,000 |
| Investing Cash Flow | $-363 | $-7,352 | $-24,930 | $-21,554 | $-9,082 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 39,550 | N/A | 39,957 | 1,673 |
| Debt Repayment | N/A | -43,000 | N/A | N/A | -1,673 |
| Common Stock Issued | 76,869 | 140,858 | 41,857 | N/A | 165,854 |
| Other Financing Activity | -185 | -1,015 | 10,240 | -874 | 125,210 |
| Financing Cash Flow | $76,684 | $136,393 | $52,097 | $39,083 | $291,064 |
| Beginning Cash Position | 146,540 | 90,517 | 151,740 | 251,253 | N/A |
| End Cash Position | 141,636 | 146,540 | 90,517 | 151,740 | 251,253 |
| Net Cash Flow | $-4,904 | $56,023 | $-61,223 | $-99,513 | $251,253 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,225 | -73,018 | -88,390 | -117,042 | -30,729 |
| Capital Expenditure | -374 | -3,869 | -20,619 | -15,304 | -82 |
| Free Cash Flow | -81,599 | -76,887 | -109,009 | -132,346 | -30,811 |